Access brought to you by: LOCKSS
Login
Algorithm for the Diagnoses and Treatment of Hepatocellular Adenoma
CRP, C-reactive protein; GS, glutamine synthetase; HCA, hepatocellular adenoma; HCC, hepatocellular carcinoma; HNF1A, hepatocyte nuclear factor 1 alpha; IHC, immunohistochemistry; LFABP, liver-type fatty acid-binding protein; MRI, magnetic resonance imaging; OC, oral contraception; SAA, serum amyloid A.
Adapted with permission of AGA Institute, from Nault JC et al. Hepatocellular Benign Tumors—From Molecular Classification to Personalized Clinical Care. Gastroenterology. 2013;144:888–902. Copyright © 2013. Permission conveyed through Copyright Clearance Center, Inc.
Using the Genotype-Phenotype Hepatocellular Adenoma Classification for Personalized Treatment
CRP, C-reactive protein; HCA, hepatocellular adenoma; HCC, hepatocellular carcinoma; HNF1A, hepatocyte nuclear factor 1 alpha; LFABP, liver-type fatty acid-binding protein 1; MODY3, maturity-onset diabetes of the young type 3; NT, normal tissue; SAA, serum amyloid A; T2W, T2-weighted.
Adapted with permission of AGA Institute, from Nault JC et al. Hepatocellular Benign Tumors—From Molecular Classification to Personalized Clinical Care. Gastroenterology. 2013;144:888–113; 902. Copyright © 2013. Permission conveyed through Copyright Clearance Center, Inc.
Thank you for your interest in spreading the word on MD Conference Express.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.